Digital health company MedPal AI (LON: MPAL) has received formal approval from the Norfolk and Waveney Integrated Care Board for the change of ownership of the NHS pharmacy contract held by Universal Pharmacy, which is in administration and the assets were acquired on 1 October. The relevant licences are no longer issued so the acquisition enabled the entry to this market. The share price increased 12.1% to 8.125p. The August placing and offer price was 4p.
Healthier snacks supplier Tooru (LON: TOO) says gluten and free-from Juvela has gained a new large UK retailer for its new OAF brand products, although the launch will not be until Easter. OAF is currently sold in Tesco. Plant-based nutrition business Pulsin has secured a European distributor, and sales will start in January. The share price recovered 12% to 0.28p.
Supercapacitors developer Cap-XX (LON: CPX) chairman Dr Graham Cooley has bought 24 million shares at 0.265p each. He owns 10.4%. The share price rose 10.7% to 0.31p.
Abingdon Health (LON: ABDX) has won a $2m contact with a US company for the development and scaling up to manufacture of a semi-quantitative, multiplex lateral flow test system for multiple analytes. This contract will be handled in Wisconsin. The share price improved 10.3% to 8p.
Promotions and loyalty software provider Eagle Eye (LON: EYE) has secured a five-year contract with one of the largest North American food retailers. One of the retailer’s five brands will use the Eagle Eye Air platform for e-commerce business. There is potential for work with the other brands if the initial deal is successful. Eagle Eye has won other new contracts this year, but the full benefits will not come through next year when they are all up and running. The loss of a customer will lead to a dip in revenues this year before a return to the growth trend in 2026-27. The share price gained 9.02% to 278p.
FALLERS
Buccaneer Energy (LON: BUCC) revealed that the Alla #1 well in the Pine Mills field in Texas, where it owns a 32.5% interest, does not contain commercial hydrocarbons. The well will be abandoned. The rig will be moved to drill the Fouke #4 well. The share price slumped 32.8% to 0.00975p.
Shuka Minerals (LON: SKA) is still waiting for the promised funds to pay the cash consideration for the acquisition of Leopard Exploration and Mining and the Katwe zinc mine in Zambia. Gathoni Muchai Investments says it will pay $350,000 of the $1.35m cash injection in the coming days and the est by the end of November. The share price declined 14.3% to 4.5p.
Food allergy tests supplier Cambridge Nutritional Science (LON: CNSL) reported a dip in interim revenues from £4.1m to £3.9m and a doubled loss of £400,000. There were weaker sales in Europe and management warns that full year revenues will be lower than last year. Previously they were expected to be flat. Cavendish expects revenue to fall from £8.3m to £7.5m, although the loss should be similar to the interim level. There is growth in the UK and India. The sales team is being restructured. There is £3.6m in the bank. The share price fell 15.1% to 2.25p.